Hematologic malignancies
Clinical research includes Richter syndrome arising from chronic lymphocytic leukemia, with interest in treatment-sensitive disease biology and immune-based combinations.
- B-cell lymphoma transformation
- Chronic lymphocytic leukemia
- Immunotherapy combinations
Work in this area reflects attention to aggressive lymphoid disease and tumor response in relapsed or transformed blood cancers.
Inflammatory and autoimmune cardiac disease
The sponsor funds studies in inflammatory cardiomyopathy, chronic myocarditis, and severe cardiac inflammation, with a strong focus on inflammatory mechanisms affecting ventricular function and rhythm.
- Myocarditis
- Inflammatory cardiomyopathy
- Heart failure phenotypes
Research also addresses cardiac inflammation linked to pro-arrhythmic risk and supportive medical management.
Colorectal cancer
Studies cover colon cancer and locally advanced rectal cancer, including biologically defined pMMR/MSS colorectal cancer and rectal tumors managed with organ-preserving strategies.
- Locally advanced rectal cancer
- Colon cancer
- Mismatch repair proficient disease
Clinical interest extends to neoadjuvant treatment, tumor response assessment, and disease control in advanced gastrointestinal malignancy.
Perioperative and immune-based oncology
Research activity includes immune checkpoint therapy in colorectal cancer, with exploration of neoadjuvant and pre-operative treatment approaches supported by biomarker evaluation.
- Checkpoint inhibition
- Pre-operative treatment
- Biomarker-driven oncology
These studies reflect interest in integrating immuno-oncology with surgical decision-making and response prediction.
Supportive and anti-inflammatory therapy
The sponsor also investigates colchicine, corticosteroid therapy, and vitamin C in settings where inflammation, cardiac injury, or cancer-related immune modulation are central concerns.
- Anti-inflammatory treatment
- Supportive care
- Immune modulation
These areas show continued involvement in therapeutic strategies for cardiovascular inflammation and solid tumor management.
